Clinical Trials Browser

Expanded_access × Thoracic × 30 days × Clear all

Carcinoma, Non-Small-Cell Lung

NCT06751524 2026-05-15

Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT06834074 2026-05-14

NVL-655-EAP

Available

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04830202 2026-05-13

Expanded Access to Telisotuzumab Vedotin

Temporarily not available

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07535359 2026-05-06

Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer

Available

Thoracic

Small Cell Lung Carcinoma

Clinical Trials

An EAP Treatment Protocol of Zipalertinib

Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

NVL-655-EAP

Expanded Access to Telisotuzumab Vedotin

Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer